This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A press release issued by Spain’s Ministry of the Interior on Friday initially sounds straightforward. Based on a complaint filed by the Alliance for Creativity and Entertainment, in November 2022 an investigation was launched to identify those responsible for two websites that marketed a service that allegedly violated the rights of ACE members. “The complex computer and banking investigation carried out, together with several police investigation techniques, allowed the specialists
Press Release: 6/2/2024 Engineering leadership must embrace AI in the innovation process. Rochester, June 3 – IP.com is excited to unveil IQ Ideas+ 3.0, featuring Compass AI , a revolutionary new solution that transforms enterprise ideation and problem-solving, delivering enhanced ROI. Utilizing cutting-edge generative artificial intelligence (AI), Compass AI offers a structured approach to creativity, intelligently guiding users through a structured approach to explore, refine, and deve
In Dragon Intellectual Property LLC v. Dish Network LLC, - (Fed. Cir., May 20, 2024), a divided panel of the U. S. Court of Appeals for the Federal Circuit held that a prevailing defendant in an otherwise “exceptional” patent infringement case could not recover attorney fees expended in a parallel inter partes review (IPR) proceeding because the defendant’s initiation of the IPR was “voluntary.
Image: Shutterstock (AI Assisted) In my last blog post, I discussed the annual Special 301 Report issued by the Office of the US Trade Representative (USTR).
Software is complex, which makes threats to the software supply chain more real every day. 64% of organizations have been impacted by a software supply chain attack and 60% of data breaches are due to unpatched software vulnerabilities. In the U.S. alone, cyber losses totaled $10.3 billion in 2022. All of these stats beg the question, “Do you know what’s in your software?
The fight against counterfeiting remains as topical as ever [ IPKat here , here or here ]. Dematerialisation is speeding up and facilitating inter alia access to products that could be described as counterfeits [ IPKat here ]. Against this backdrop, this Kat has taken note of a new French draft law dated 28 May 2024 aimed at supplementing the existing enforcement arsenal.
The glamour of the jet age! It can only get better when LIKELIHOOD OF CONFUSION® touches down soon at #INTA2015! pic.twitter.com/aG7AA7YDGT — Likelihood TM Blog (@likely2confuse) May 3, 2015 Originally posted 2015-05-03 11:08:21. Republished by Blog Post Promoter The post Out to launch appeared first on LIKELIHOOD OF CONFUSION™.
The recent Board of Appeal case T 0209/22 is yet another decision demonstrating the relatively permissive approach in Europe to medical use inventions. The patent related to the medical use of a combination of known drugs. The claim was supported by data described in the application from a phase I clinical trial in healthy volunteers. The patent did not include any patient data for the drug combination.
The recent Board of Appeal case T 0209/22 is yet another decision demonstrating the relatively permissive approach in Europe to medical use inventions. The patent related to the medical use of a combination of known drugs. The claim was supported by data described in the application from a phase I clinical trial in healthy volunteers. The patent did not include any patient data for the drug combination.
Guest Post by Sarah Burstein, Professor of Law at Suffolk University Law School LKQ Corp. v. GM Global Tech. , 21-2348 (Fed. Cir. 2024) (en banc). In its decision in LKQ v. GM , the en banc Federal Circuit may have raised as many questions as it answered. For now, I’d like to focus on one: What counts as a proper primary reference under LKQ ? While the Federal Circuit overruled the Rosen requirement that a primary reference look “basically the same” as the claimed design, the court did not over
Photo by Jonathan Kemper on Unsplash On 7 May 2024, Open AI published its approach to data and AI (ADAI). This statement sets out OpenAI’s vison for a ‘social contract for content in AI’. In this vision, OpenAI shares its own perception of its contribution to creative ecosystems, but also its understanding of some of the legal implications of its business model.
After it was referred back in 2021, a few days ago the Grand Board of the European Union Intellectual Property Office finally issued its long-awaited decision concerning an application to register the figurative sign ‘COVIDIOT’ (below) as an EU trade mark for the following goods: Class 6: Metal clips. Class 9: Computer gaming software; Mobile apps. Class 28: Board games; Toys.
We organize all of the trending information in your field so you don't have to. Join 9,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
117 
Let's personalize your content